文献速递关节外科运动医学

中央髋臼减压治疗中央髋臼狭窄的中期疗效:与匹配对照组的比较

Midterm Outcomes in Patients After Central Acetabular Decompression for Central Acetabular Stenosis: A Comparison With a Matched Control Group.
PubMed 文献 · Am J Sports Med · 2025-05-22

该队列研究纳入因股髋撞击症行初次髋关节镜手术并同期因中央髋臼狭窄行中央髋臼减压的189例患者,155例(82.0%)完成至少5年随访,5年无关节置换生存率为80.6%(125/155);与倾向评分匹配的无中央髋臼狭窄对照组相比,减压组软骨损伤率更高、无关节置换生存率更低(P < .01),但未行关节置换者的术后疗效评分与满意度与对照组相当。

要点

  • 中央髋臼狭窄患者行中央髋臼减压后5年无关节置换生存率为80.6%(125/155)。
  • 未行关节置换者术后改善持久(P < .001)且满意度高。
  • 严重髋臼软骨缺损最能预测进展为关节置换。

核心结论

  • 中央髋臼狭窄患者在因股髋撞击症行初次髋关节镜手术时行中央髋臼减压,至少5年随访下术后改善持久且手术满意度高。
  • 中央髋臼减压组术中软骨损伤率显著高于对照组,无关节置换生存率低于对照组。
  • 未行关节置换的中央髋臼减压患者中81%获得显著改善,且与对照组相当。
  • 作者认为,在合理预期下,合并中央髋臼狭窄的股髋撞击症患者可通过先进关节镜技术成功治疗。

研究设计与样本

  • 队列研究,证据等级3。
  • 回顾性审查前瞻性收集数据的手术登记系统,纳入因股髋撞击症行初次髋关节镜手术中识别出中央髋臼狭窄并接受中央髋臼减压的患者。
  • 共189例符合条件患者,155例(82.0%)完成至少5年随访。
  • 同期以术前年龄、性别、体重指数和Tönnis分级进行倾向评分匹配,形成无中央髋臼狭窄的股髋撞击症髋关节镜手术对照组。

主要发现

  • 155例完成至少5年随访的患者平均年龄45.9 ± 10.8岁,女性90例(58.1%)。
  • 5年时点无关节置换生存率为80.6%(125/155)。
  • 未行关节置换者术后改善持久(P < .001),满意度高。
  • 多因素分析显示严重髋臼软骨缺损最能预测进展为关节置换。
  • 无中央髋臼狭窄对照组软骨损伤率更低、无关节置换生存率更高(P < .01)。

关键数值与推荐

  • 中央髋臼狭窄定义为髋臼窝内的骨赘。
  • 主要结局为术后5年内转为关节置换。
  • 次要结局包括翻修关节镜手术和患者报告结局评分。
  • 5年无关节置换生存率为80.6%(125/155)。
  • 未行关节置换者术后改善P < .001;中央髋臼减压组与对照组无关节置换生存率比较P < .01。

临床怎么用

  • 作者认为,在合理预期下,合并中央髋臼狭窄的股髋撞击症患者可通过先进关节镜技术成功治疗。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Central acetabular stenosis (CAS), defined as an osteophyte within the acetabular fossa, is associated with higher rates of femoral head chondral damage and, when left untreated, inferior short-term outcomes after hip arthroscopic surgery. Central acetabular decompression (CAD) is an arthroscopic technique to resect the osteophyte and resurface the acetabular fossa to improve contact mechanics of the femoral head. PURPOSE: The primary aim was to provide the 5-year hip preservation rate and patient-reported outcomes in patients undergoing hip arthroscopic surgery for femoroacetabular impingement (FAI) concomitantly with CAD for CAS. A secondary aim was to compare outcomes in patients treated with CAD for CAS to a propensity score-matched control group of patients without CAS. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: A surgical registry with prospectively collected data was reviewed for patients who underwent CAD for CAS identified during primary hip arthroscopic surgery for FAI. The primary outcome for the study was conversion to arthroplasty within 5 years postoperatively. Secondary outcomes included revision arthroscopic surgery and patient-reported outcome scores. Multivariate regression analysis was performed to evaluate the risk factors for progression to arthroplasty. A propensity score-matched control group based on preoperative age, sex, body mass index, and Tönnis grade was formed of patients undergoing hip arthroscopic surgery for FAI without CAS to evaluate the differences in outcomes between the 2 groups. RESULTS: There were 155 of 189 eligible patients (82.0%) who had a minimum 5-year follow-up. Within this cohort, the mean age was 45.9 ± 10.8 years, with 90 female patients (58.1%). At the 5-year time point, the arthroplasty-free survivorship rate was 80.6% (125/155). For patients not requiring arthroplasty, significant postoperative improvements were durable (P < .001), with high satisfaction. On multivariate analysis, severe acetabular chondral defects were most predictive of conversion to arthroplasty. The control group of patients with FAI without CAS demonstrated lower rates of chondral damage and higher rates of arthroplasty-free survivorship (P < .01). For patients not requiring arthroplasty, postoperative outcome scores, rates of achieving clinically relevant outcome thresholds, and satisfaction with surgery were comparable between the CAD and control groups. CONCLUSION: Patients with CAS undergoing CAD during primary hip arthroscopic surgery for FAI had durable postoperative improvements and high satisfaction with surgery at a minimum 5-year follow-up. As expected, intraoperative chondral damage rates were significantly greater, and arthroplasty-free survivorship rates were lower, in the CAD group compared with the control group. Nonetheless, 81% of patients undergoing CAD who did not require arthroplasty had significant improvements that were comparable with the control group. We conclude that, with appropriate expectations, patients with FAI and CAS may be treated successfully with advanced arthroscopic techniques.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Kuhns BD, Kahana-Rojkind AH, McCarroll TR, et al. Midterm Outcomes in Patients After Central Acetabular Decompression for Central Acetabular Stenosis: A Comparison With a Matched Control Group. Am J Sports Med. 2025. PMID: 40401566. doi:10.1177/03635465251338064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。